Severe stomach pain on Mounjaro: what's happening and when to get help

Step 1, Understand the two distinct pain patterns

Not all stomach discomfort on Mounjaro is the same, and the distinction matters. The most common gastrointestinal effects (nausea, loose stools, constipation, reflux, or a general unsettled feeling) are well-documented in trial data and typically cluster around the start of treatment or after a dose step up. They are usually manageable, and for most people they ease as the body adjusts.

Severe stomach pain is a different picture. If the pain is sharp or unrelenting, if it sits in the upper abdomen, or if it spreads towards the back (with or without vomiting), that combination of features is associated with pancreatitis. Gallbladder problems (including gallstones and inflammation) are another possibility; Mounjaro affects bile production and gallbladder motility. Neither of these conditions announces itself gently.

Learning to tell the difference isn't about diagnosing yourself. It's about knowing that persistent, intense abdominal pain during tirzepatide treatment is the signal to stop waiting and get assessed. Our guide to stomach pain on Mounjaro walks through the full range of GI effects in more detail, including the milder ones.

Step 2 (Know when to call for help immediately

In January 2026, the MHRA issued a Drug Safety Update for GLP-1 receptor agonist medicines) including tirzepatide, drawing prescribers' and patients' attention to the risk of acute pancreatitis. The update is formal and specific: seek urgent medical attention for severe, persistent abdominal pain, especially if it radiates to the back. You can review the MHRA's safety communications directly via the MHRA Drug Safety Updates index.

Call 999 or go to A&E if the pain is severe and sudden. Call 111 if you're unsure and need guidance. Either way, tell the clinician you are taking Mounjaro (tirzepatide). Pancreatic enzyme levels are checked by a blood test; knowing you're on a GLP-1/GIP medicine is relevant information for the clinician interpreting your results.

Gallbladder symptoms can also present as sharp pain in the upper right abdomen, sometimes with fever or jaundice. If dehydration is a concern because of repeated vomiting, that adds urgency. Pain at night that wakes you is worth reading about separately, we've covered Mounjaro stomach pain at night for people in that specific situation.

Step 3, Report the symptom and decide next steps with your prescriber

Once you've been assessed and the immediate concern is addressed, you'll need a clinical conversation about whether to continue, pause, or stop Mounjaro. That decision sits with your prescriber, not with you alone, and not with a checklist. If you experienced genuine pancreatitis or a confirmed gallbladder event, Mounjaro is typically not restarted.

Patients can also report suspected side effects through the MHRA's Yellow Card scheme. This isn't just bureaucracy, it's how the MHRA monitors real-world safety signals beyond clinical trials. The scheme accepts reports from patients directly, not only from healthcare professionals.

For people who stopped treatment because of a severe GI event and are wondering whether an alternative approach might suit them, the broader landscape of weight-loss treatment options is worth exploring with a clinician. And if your pain appeared after stopping Mounjaro rather than during it, the pattern is different again; our page on stomach pain after stopping Mounjaro covers what's known there.

What else can cause upper abdominal pain on tirzepatide?

Upper abdominal pain specifically has a few plausible causes in someone on Mounjaro. Oesophageal and gastric reflux can intensify when gastric emptying slows, and tirzepatide does slow it. Constipation (sometimes underestimated as cramping) can cause diffuse abdominal pain. Gastroparesis (delayed stomach emptying beyond the usual slowing effect) is a rarer but documented concern with GLP-1 medicines and can produce persistent upper-abdominal discomfort, nausea, and a feeling of fullness that doesn't shift.

Our page specifically on upper stomach pain on Mounjaro goes through these mechanisms in more detail. The reason it matters to distinguish upper from lower, and localised from diffuse, is that a clinician uses that geography when deciding what to investigate first.

Mounjaro is a dual GIP and GLP-1 receptor agonist, the only medicine of its type licensed in the UK for weight management. Understanding more about how tirzepatide works as a treatment can help put these side-effect mechanisms in context; the tirzepatide overview on our site covers the mechanism clearly. For context on how costs and treatment access fit together, the background on Mounjaro's UK price changes is relevant reading if you're weighing up private treatment.